← Leaderboards
Bob S Carter
Massachusetts General Hospital
$9,693,982
Attributed
$16,836,942
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,836,942 · 9
By mechanism
R01$6,206,489 · 3
U01$3,984,889 · 1
UH3$3,022,165 · 1
P01$1,874,545 · 2
UH2$1,072,378 · 1
K08$676,476 · 1
Top collaborators
- Hakho Lee9 shared
- Fred H Hochberg7 shared
- Johan Skog5 shared
- Leonora Balaj1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Hakho Lee$15,122,007
- Raymond T Chung$38,306,004
- Xandra Owens Breakefield$30,735,276
- Ralph Weissleder$110,468,710
- E. Antonio Chiocca$34,514,665
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaBiopsyTumorDiagnosisSamplingBiological MarkersPerformanceBrain NeoplasmsMutationSensitivity And SpecificityTissuesMonitorDigitalExtracellularDetectionBloodDiagnosticTumor TissueProspectiveCollaborationsMolecularReproducibilityBaseExtracellular Vesicles
Grant awards (38)
Molecular subtyping of brain tumors using a blood-based multiplexed assay$678,228
R01 · FY2025 · CA
Standardized Molecular Analyses of Glioma EVs$557,524
R01 · FY2024 · CA · contact PI
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring$605,638
R01 · FY2023 · CA · contact PI
Standardized Molecular Analyses of Glioma EVs$577,860
R01 · FY2023 · CA · contact PI
Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas$773,953
U01 · FY2022 · CA · contact PI
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring$614,253
R01 · FY2022 · CA · contact PI
Standardized Molecular Analyses of Glioma EVs$602,790
R01 · FY2022 · CA · contact PI
Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas$808,800
U01 · FY2021 · CA · contact PI
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring$635,399
R01 · FY2021 · CA · contact PI
Standardized Molecular Analyses of Glioma EVs$624,914
R01 · FY2021 · CA · contact PI
Core B - Clinical Sample and Biostatistics Core$160,426
P01 · FY2021 · CA · contact PI
Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas$808,800
U01 · FY2020 · CA · contact PI
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring$660,849
R01 · FY2020 · CA · contact PI
Standardized Molecular Analyses of Glioma EVs$649,034
R01 · FY2020 · CA · contact PI
Core B - Clinical Sample and Biostatistics Core$160,426
P01 · FY2020 · CA · contact PI
Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas$784,536
U01 · FY2019 · CA · contact PI
Core B - Clinical Sample and Biostatistics Core$200,394
P01 · FY2019 · CA · contact PI
Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas$808,800
U01 · FY2018 · CA · contact PI
Core B - Clinical Sample and Biostatistics Core$160,425
P01 · FY2018 · CA · contact PI
exRNA Biomarkers for Human Glioma$960,890
UH3 · FY2017 · TR · contact PI
Core B - Clinical Sample and Biostatistics Core$178,175
P01 · FY2017 · CA · contact PI
exRNA Biomarkers for Human Glioma$972,585
UH3 · FY2016 · TR · contact PI
Biorepository core and bioststistics$204,486
P01 · FY2016 · CA · contact PI
exRNA Biomarkers for Human Glioma$984,048
UH3 · FY2015 · TR · contact PI
Biorepository core and bioststistics$205,235
P01 · FY2015 · CA · contact PI
exRNA Biomarkers for Human Glioma$104,642
UH3 · FY2015 · TR · contact PI
exRNA Biomarkers for Human Glioma$494,879
UH2 · FY2014 · TR · contact PI
Biorepository core and bioststistics$198,296
P01 · FY2014 · CA · contact PI
exRNA Biomarkers for Human Glioma$77,500
UH2 · FY2014 · TR · contact PI
exRNA Biomarkers for Human Glioma$499,999
UH2 · FY2013 · TR · contact PI
Biorepository core and bioststistics$192,874
P01 · FY2013 · CA · contact PI
Biorepository core and bioststistics$213,808
P01 · FY2012 · CA · contact PI
GENETICALLY ENGINEERED ANTI ANGIOGENIC ANTI GLIOMA CTL'S$67,676
K08 · FY2005 · CA
GENETICALLY ENGINEERED ANTI ANGIOGENIC ANTI GLIOMA CTL'S$135,351
K08 · FY2004 · CA
GENETICALLY ENGINEERED ANTI ANGIOGENIC ANTI GLIOMA CTL'S$135,351
K08 · FY2003 · CA
GENETICALLY ENGINEERED ANTI ANGIOGENIC ANTI GLIOMA CTL'S$67,676
K08 · FY2002 · CA
GENETICALLY ENGINEERED ANTI ANGIOGENIC ANTI GLIOMA CTL'S$135,351
K08 · FY2001 · CA
GENETICALLY ENGINEERED ANTI ANGIOGENIC ANTI GLIOMA CTL'S$135,071
K08 · FY2000 · CA